A team of University of Chicago scientists has shown how two proteins locate and repair damaged genetic material inside cells. Because one of the proteins detects and repairs DNA damage that may result from a certain type of cancer therapy, the researchers raised the possibility of designing a molecule that could interfere with the repair process, making cancer treatment more effective. Data collection took place on beamlines 14-BM-C (BioCARS) and 19-BM-D (SBC-CAT) of the Advanced Photon Source at the U.S. Department of Energy’s Argonne National Laboratory.
In their Nature paper, the scientists determined, for the first time, the crystal structures (showing the three-dimensional framework of atoms) of two related DNA-repair proteins bound to double-stranded DNA: a bacterial protein called AlkB, and a corresponding human protein, ABH2. Scientists had been seeking the structures of these proteins to better understand how they perform their key roles in repairing DNA.
The bacterial protein can bind to either single- or double-stranded DNA. The strands separate during the replication process, but the bacterial protein avoids the latter.
Chuan He, Assistant Professor in Chemistry, led the team. His co-authors included Phoebe Rice, Associate Professor in Biochemistry and Molecular Biology at the University of Chicago, and five researchers from his laboratory: Cai-Guang Yang, Chengqi Yi, Erica Duguid, Christopher Sullivan, and Xing Jian. Their work was supported by the National Institutes of Health, the W.M. Keck Foundation and the Arnold and Mabel Beckman Foundation.
“This is very bizarre, because most other DNA repair proteins prefer double-stranded,” He said. The AlkB protein avoids double-stranded DNA because binding it takes more energy.
“Double-stranded DNA is rigid. Single-stranded is very flexible,” He explained. “You can cause all kinds of distortion in single-stranded without paying much energetic penalty.”
Many labs have unsuccessfully attempted to solve the structure of the bacterial protein with double-stranded DNA. They failed because this family of proteins binds DNA weakly, which foils the application of traditional crystallographic methods, He said. His team reinforced the complex by cross-linking the DNA to the protein.
Previous crystal structures of this protein included only a very short, single-stranded segment of DNA, and did not reveal all of its interactions with larger, more biologically relevant strands of DNA.
“The technique that they used to grow these crystals is very clever,” said Rice, who served as the team’s crystallographer. “It’s a nice application of chemistry to solving important questions in biology. Knowing which pieces of the enzyme are important for interacting with double-stranded DNA and which pieces are missing when it would prefer a single strand will help us to predict the functions of related proteins.”
Said He: “We’re now applying this same strategy to all kinds of other protein-DNA complexes.”
The AlkB and ABH2 proteins repair alkylation damage to DNA, including the damage caused by alkylating cancer treatments. Alkylation is the addition of certain chemical groups to DNA and is particularly harmful to rapidly growing cells such as cancerous ones.
In an unexpected development last year, a team of European researchers published studies that identified an obesity gene in humans that belongs to the same family of proteins as AlkB. A defect in this gene, FTO, is associated with a weight gain of nearly seven pounds.
“It’s surprising and exciting to see that the demethylation function is linked to obesity,” He said. “Methylation is a type of alkylation that is used to regulate gene expression.” One of his future goals is to determine the function of the FTO protein.
Among their many functions, proteins control chemical reactions in the cell by turning genes off and on. “This family of proteins might use demethylation as a signal to regulate gene activation,” he said. “But this type of demethylation by AlkB and FTO has never been linked to gene activation in the past.”
Contact: C. He, [email protected]
See: Cai-Guang Yang, Chengqi Yi, Erica M. Duguid, Christopher T. Sullivan, Xing Jian, Phoebe A. Rice, and Chuan He, "Crystal structures of DNA/RNA repair enzymes AlkB and ABH2 bound to dsDNA," Nature 452, 961 (24 April 2008). DOI:10.1038/nature06889
The original news release can be found at: https://news.uchicago.edu/?asset_id=1340
See also: “Fixing Chemotherapy,” at spectroscopyNOW.com
This work was supported by the National Institutes of Health (GM071440 to C.H. and a PCBio fellowship for C.T.S.), the W.M. Keck Foundation Distinguished Young Scholar in Medical Research Program (C.H.), and the Arnold and Mabel Beckman Foundation Young Investigator Program (C.H.). Financial support for the APS beamlines comes from the National Institutes of Health and the United States Department of Energy. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.
Argonne National Laboratory brings the world's brightest scientists and engineers together to find exciting and creative new solutions to pressing national problems in science and technology. The nation's first national laboratory, Argonne conducts leading-edge basic and applied scientific research in virtually every scientific discipline. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state and municipal agencies to help them solve their specific problems, advance America 's scientific leadership and prepare the nation for a better future. With employees from more than 60 nations, Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy's Office of Science.